This is to inform you that as per the SEBI (Prohibition of Insider trading ) regulations 2015 read with BSE Circular Ref No LIST/COMP/01/2019-20 and as per the terms of Code of conduct for Prevention of Insider Trading Regulations, the trading window for dealing in the Company shares shall remain closed from Friday, July 1, 2022 till the end of 48 hours after declaration of financial results for the quarter and year ending on 30th June 2022 for specified designated persons as defined in the code. The same has been informed to the Directors and designated persons of the Company
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are submitting herewith the Annual Secretarial Compliance Report of the Company for the financial year ended 31st March, 2022 duly issued by M/s. Eswaramoorthy and company Practicing Company Secretaries, Coimbatore
Please find enclosed herewith the copy of Newspaper Advertisement published on May 26th and May 27th, 2022 in Tamil Murasu (Coimbatore Edition) and Business Standard (All India Edition) in respect of financial results approved by the Board at its meeting held on May 25,2022.
With reference to the captioned subject matter and pursuant to Regulation 30 (6) of the Listing Regulations read with Para A of Part A of Schedule III of the said regulations, we are delighted to inform that on recommendation of Nomination & Remuneration committee, the Board of Directors of the Company in its meeting held on Wednesday has appointed Ramanujam Reghunathan (Membership Number- FCA-024458) as the Chief Financial Officer of the Company with effect from May 25 2022. As per the provisions of Section 203 of the Companies Act 2013 read with relevant applicable rules Mr. Ramanujam Reghunathan shall be a whole time key managerial personnel of the company.
Lotus Eye Hospital And Institute Ltd has informed BSE that the Board of Directors of the Company will be meeting on May 25, 2022, inter alia, to consider the following:1. Audited Standalone Financial Results of the company for the quarter and year ended March 31, 2022.2. Consideration and proposed recommendation of Final DividendFurther, with reference to Company''s earlier intimation March 31, 2022, in accordance with SEBI (Prohibition of Insider Trading) Regulations. 2015 and the Code of Conduct for Insiders of the Company, the trading window will re-open from May 30, 2022 onwards.
Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve 1. Audited Standalone Financial Results of the company for the quarter and year ended March 31, 2022. 2. Consideration and proposed recommendation of Final Dividend